Search results
TIME100 Health: Ivan Cheung
Time via Yahoo News· 1 week agoThat conviction proved prescient when the U.S. Food and Drug Administration approved lecanemab in 2023—and aducanumab’s manufacturer ...
Medicare Says It Expects To Spend $3.5 Billion In 2025 On Alzheimer’s Drug Leqembi, But This Is...
Forbes· 1 week agoSkepticism may be warranted when the Centers for Medicare and Medicaid Services’ Office of the...
Navigating Alzheimer's care: The promises and limits of a new drug
KPBS San Diego· 1 week agoAlzheimer's Disease and related dementias take a heavy toll on individuals and their caregivers. New...
